How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Guides and Reports
Report Demonstrates Hospitals Value Group Purchasing Organizations
 
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
AHRMM Cost, Quality and Outcomes (CQO) Movement
The AHRMM Cost, Quality, and Outcomes (CQO) Movement frames the critical role supply chain professionals play in driving high quality care, at a more…
On-Demand Educational Webinars
Service Contracts: Impacting the Total Cost of Ownership